Cyclic Glycine-Proline and Ipamorelin Interaction
Cyclic Glycine-Proline and Ipamorelin have an interaction requiring monitoring for interaction with 47% confidence. Both Cyclic Glycine-Proline and Ipamorelin affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Both compounds affect the brain, so monitoring these systems is recommended.
Compound Profiles
Cyclic Glycine-Proline
IGF-1 Bioavailability Regulator & Neuroprotective Peptide
Competes with IGF-1 for IGFBP-3 binding, normalizing bioavailable IGF-1 levels. Acts as positive allosteric modulator of AMPA and GABA-A receptors.
View full profileIpamorelin
Growth Hormone Secretagogue | Selective GHRP
Binds selectively to ghrelin receptors in pituitary gland, stimulating natural GH release with direct systemic delivery via injection, consistent GH pulse stimulation, no significant cortisol or prolactin elevation, and minimal hunger response..
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Cyclic Glycine-Proline with Ipamorelin?
Yes, but with caution. Both Cyclic Glycine-Proline and Ipamorelin affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Regular monitoring is advised.
Is Cyclic Glycine-Proline and Ipamorelin safe together?
Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: insulin disrupting. Monitor accordingly.
What are the interactions between Cyclic Glycine-Proline and Ipamorelin?
Both Cyclic Glycine-Proline and Ipamorelin affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.
How should I time Cyclic Glycine-Proline and Ipamorelin?
Cyclic Glycine-Proline has a half-life of Extended stability (more stable than linear GPE precursor) and Ipamorelin has a half-life of ~2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.